The worst performer among these stocks has soared more than 70% over the last 12 months.
News & Analysis: DexCom
Insulet's wearable insulin pumps will be integrated with blood glucose monitors from both companies.
Shares have soared more than 400% in just two years.
Investors loved the medical device maker's great Q4 results.
DXCM earnings call for the period ending December 31, 2019.
The medical-device maker delivered good news across the board for the quarter.
Shares of the medical device manufacturer gained ground on the news.
Shares of the insulin pump maker continued their powerful performance last month.
DexCom's stock is now at all-time highs. Can this growth stock keep churning higher?
Both medical device stocks have characteristics investors should consider.